How is the Superficial Punctate Keratitis Treatment Market Poised for Growth: Trends and Opportunities Through 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the market size evolved in recent years?
In the past few years, the market size for the treatment of superficial punctate keratitis has experienced robust growth. The market value expects to rise from $4.91 billion in 2024 to about $5.25 billion in 2025, having a compound annual growth rate (CAGR) of 6.9%. Factors that contributed to past growth include a higher occurrence of ocular surface disorders, enhanced consciousness about eye health, increased demand for topical therapies, a growing older population, advancements in healthcare facilities, and increased research and development activities in the field of ophthalmology.
What are the predictions for the market size in the coming years?
The market for treating superficial punctate keratitis is projected to witness considerable growth in the forthcoming years, predicted to balloon to $6.79 billion by 2029, increasing at a compound annual growth rate (CAGR) of 6.7%. This growth during the projected period can be credited to factors such as the surging incidence of dry eye syndrome, amplified usage of contact lenses, skyrocketing awareness regarding eye health, the burgeoning healthcare structure in developing economies, and an augmented focus on personalized treatments. Notable trends anticipated during the forecasted period encompass the enhancement in drug formulations promoting improved corneal recovery, progression in targeted biologics, breakthroughs in ocular lubricants and artificial tears, implementation of nanotechnology in drug delivery methods, breakthroughs in minimally invasive surgical procedures, the application of regenerative therapies including stem cells, and the incorporation of digital diagnoses for tailored treatment approaches.
Get your market report here!
What are the major factors driving growth in the market?
The surge in instances of eye disease is anticipated to propel the superficial punctate keratitis treatment market in the future. Eye diseases encompass a variety of visual and ocular health issues, from infections and structural anomalies to degenerative disorders. The escalating frequency of these diseases is being fueled by ageing societies, extended screen usage, diabetes, and environmental influences such as pollution and UV light exposure. Treatments for superficial punctate keratitis, such as lubricating eye drops, antibiotics and anti-inflammatory drugs, are administered to relieve pain, diminish inflammation, and facilitate healing in a variety of ocular diseases that damage the corneal surface. For example, the Office for Health Improvement and Disparities reported in May 2024 that over 8.9 million vision outpatient visits occurred in England in the financial year of 2023, reflecting a per capita rate of 15,362 per 100,000 people, a rise from 14,613 in the previous year. As such, the growing occurrence of eye disease is steering the growth of the superficial punctate keratitis treatment market.
How is the global market divided into key segments?
The superficial punctate keratitis treatment market covered in this report is segmented –
1) By Product Type: Pharmacological Treatments, Surgical Treatments, Minimally Invasive Treatments, Digital Health Solutions (Telemedicine And Mobile Apps), Other Eye Care Solutions
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Ophthalmology Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) By Pharmacological Treatments: Antibiotics, Antiviral Agents, Anti-inflammatory Drugs, Lubricating Eye Drops, Immunomodulators
2) By Surgical Treatments: Corneal Debridement, Amniotic Membrane Transplantation, Other Surgical Interventions
3) By Minimally Invasive Treatments: Punctal Plugs, Intense Pulsed Light (IPL) Therapy, Autologous Serum Eye Drops
4) By Digital Health Solutions (Telemedicine And Mobile Apps): Remote Consultation Platforms, AI-Based Symptom Tracking Apps, Digital Therapeutics For Eye Care
5) By Other Eye Care Solutions: Specialized Contact Lenses, Nutritional Supplements, Lifestyle And Environmental Modifications
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21293&type=smp
Who are the key firms paving the way for growth in the market?
Major companies operating in the superficial punctate keratitis treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc (GSK), Alcon Inc., Bausch + Lomb Corporation, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals plc, Santen Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Dompé Farmaceutici S.p.A., OASIS Medical Inc., Bruschettini S.r.l., Allergan plc, CONTACARE Ophthalmics Pvt. Ltd., Prevego Healthcare Ltd.
Which trends are expected to transform the market?
The leading corporations in the superficial punctate keratitis treatment market are honing their focus to develop innovative solutions like eye drop formulations that manage inflammation and offer effective, non-invasive treatments for their patients. Eye drops, being liquid compounds meant for direct eye application, are utilized to curb issues like dryness, inflammation, infections, or irritation. For example, Entod Pharmaceuticals, a pharmaceutical firm based in India, launched CYCLOTEARS eye drops in India along with other international markets in May 2023. These eye drops, designed for individuals plagued by inflammatory dry eye disease (DED), are the first-of-its-kind dry eye therapy to incorporate the company’s self-emulsifying drug delivery system (SEDDS) technology – an important step forward in the treatment of eye inflammation. This state-of-the-art formulation increases the absorption and effectiveness of the medicine, providing better relief for patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21293
What regions are contributing significantly to the growth of the market?
North America was the largest region in the superficial punctate keratitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the superficial punctate keratitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hormone Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report
Biosimilar Growth Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
